Site Map
Product Pages Catalogue Numbers 1301 - 1400
| Cat. No. | Product Name & Pharmacological Action |
|---|---|
| 1302 | (S)-3,4-DCPG |
| Potent, selective mGlu8a agonist | |
| 1304 | BW-B 70C |
| 5-Lipoxygenase inhibitor | |
| 1305 | Monastrol |
| Selective inhibitor of mitotic kinesin Eg5 | |
| 1307 | Ciglitazone |
| Selective PPARγ agonist | |
| 1308 | [Nphe1]Nociceptin(1-13)NH2 |
| Selective, competitive nociceptin antagonist | |
| 1309 | PPNDS |
| Potent, selective P2X1 antagonist | |
| 1310 | UCL 1684 |
| Highly potent blocker of SKCa | |
| 1311 | MK 886 |
| Inhibitor of 5-lipoxygenase-activating protein (FLAP) | |
| 1312 | WY 14643 |
| Selective PPARα agonist | |
| 1316 | Tertiapin-Q |
| Potent, selective inhibitor of inward-rectifier K+ channels | |
| 1317 | CP 94253 hydrochloride |
| Potent, selective 5-HT1B agonist | |
| 1318 | ACPA |
Potent, selective CB1 agonist |
|
| 1319 | ACEA |
Potent, highly selective CB1 agonist |
|
| 1321 | ZM 336372 |
| Potent, selective c-Raf inhibitor | |
| 1322 | GR 113808 |
| Potent, selective 5-HT4 antagonist | |
| 1323 | Butabindide oxalate |
| CCK-inactivating serine peptidase inhibitor | |
| 1324 | RX 821002 hydrochloride |
Potent, selective α2D antagonist |
|
| 1325 | RS 100329 hydrochloride |
| Potent, subtype selective α1A antagonist | |
| 1326 | BADGE |
| PPARγ antagonist | |
| 1327 | L-655,708 |
| Selective for α5-containing GABAA receptors | |
| 1328 | Flumazenil |
| Benzodiazepine antagonist | |
| 1329 | Ryanodine |
| Ca2+ release inhibitor | |
| 1330 | Chelerythrine chloride |
| Potent protein kinase C inhibitor | |
| 1331 | Lavendustin A |
| EGFR, p60c-src inhibitor | |
| 1333 | cAMPS-Sp, triethylammonium salt |
| Cell-permeable cAMP analogue | |
| 1334 | Bafilomycin A1 |
| H+-ATPase (vacuolar) inhibitor | |
| 1336 | Calyculin A |
| Protein phosphatase 1 and 2A inhibitor | |
| 1337 | cAMPS-Rp, triethylammonium salt |
| cAMP antagonist | |
| 1339 | Anandamide |
Endogenous CB receptor agonist |
|
| 1341 | JWH 015 |
Selective CB2 agonist |
|
| 1343 | JWH 133 |
Potent, selective CB2 agonist |
|
| 1344 | SAMS Peptide |
| AMP-activated protein kinase substrate | |
| 1345 | AF-DX 384 |
Potent M2/M4 antagonist |
|
| 1346 | des-Gln14-Ghrelin (rat) |
| Endogenous ligand for GHS receptor | |
| 1347 | Nafadotride |
Highly potent, preferential D3 antagonist |
|
| 1348 | UB 165 fumarate |
Subunit selective nAChR agonist |
|
| 1349 | (R)-(-)-Rolipram |
| More active enantiomer of Cat. No. 0905 | |
| 1350 | (S)-(+)-Rolipram |
| Less active enantiomer of Cat. No. 0905 | |
| 1352 | Phospho-Glycogen Synthase Peptide-2 (substrate) |
| Glycogen synthase kinase-3 substrate (synthetic) | |
| 1353 | Akt/SKG Substrate Peptide |
| Akt/PKB substrate (synthetic) | |
| 1354 | Arvanil |
| Potent CB1 and TRPV1 (VR1) agonist/anandamide transport inhibitor | |
| 1355 | P1075 |
| Potent KATP channel opener | |
| 1356 | MG 624 |
α7 neuronal nicotinic receptor antagonist |
|
| 1357 | U 99194 maleate |
Potent, selective D3 antagonist |
|
| 1358 | Nociceptin (1-13)NH2 |
| Potent ORL1 agonist | |
| 1359 | VUF 5574 |
| Potent, selective hA3 antagonist | |
| 1361 | PD 123319 ditrifluoroacetate |
| Potent, selective non-peptide AT2 antagonist | |
| 1362 | 5'-Iodoresiniferatoxin |
| Potent, silent TRPV1 (VR1) antagonist | |
| 1363 | PD 81723 |
| Allosteric potentiator of A1 receptors | |
| 1364 | Colchicine |
| Inhibitor of tubulin | |
| 1365 | [cPP1-7,NPY19-23,Ala31,Aib32,Gln34] -hPancreatic Polypeptide |
| Potent, selective neuropeptide Y Y5 agonist | |
| 1366 | ZM 449829 |
| Potent, selective Jak3 inhibitor | |
| 1367 | ZM 39923 hydrochloride |
| Potent, selective Jak3 inhibitor | |
| 1368 | Geldanamycin |
| Selective Hsp90 inhibitor | |
| 1369 | UBP1112 |
| Group III mGlu antagonist | |
| 1370 | Sphingosine-1-phosphate |
| Bioactive lipid, binds EDG receptors | |
| 1371 | SB 200646 hydrochloride |
| 5-HT2C/2B antagonist | |
| 1372 | SB 204741 |
| Potent, selective 5-HT2B antagonist | |
| 1375 | SB 228357 |
| 5-HT2C/2B antagonist/inverse agonist | |
| 1376 | SB 218795 |
| Potent, selective non-peptide NK3 antagonist | |
| 1377 | Cromakalim |
| KATP channel opener | |
| 1378 | Levcromakalim |
| KATP channel opener. Active enantiomer of Cat. No. 1377 | |
| 1379 | SB 221284 |
| Potent, selective 5-HT2C/2B antagonist | |
| 1380 | PMPA (NAALADase inhibitor) |
| Highly potent, selective NAALADase (GCP II) inhibitor | |
| 1381 | GW 5074 |
| Potent, selective cRaf1 kinase inhibitor | |
| 1382 | L-152,804 |
| Potent, selective non-peptide NPY Y5 antagonist | |
| 1383 | BML-190 |
Potent, selective CB2 ligand |
|
| 1384 | McN-A 343 |
| Selective M1 muscarinic agonist | |
| 1385 | MRS 1334 |
| Potent, highly selective hA3 antagonist | |
| 1386 | [Ala11,22,28]VIP |
| Potent, highly selective VPAC1 agonist | |
| 1387 | Ac-RYYRWK-NH2 |
| Potent, selective ORL1 partial agonist peptide | |
| 1390 | (-)-Cytisine |
Potent, selective neuronal nicotinic agonist |
|
| 1391 | NF 449 |
| Highly selective P2X1 antagonist | |
| 1392 | VDM 11 |
Potent, selective anandamide transport inhibitor |
|
| 1393 | SB 222200 |
| Potent, selective non-peptide NK3 antagonist. Brain penetrant | |
| 1394 | (RS)-3,4-DCPG |
| AMPA/NMDA antagonist/mGlu8 agonist. Anticonvulsant | |
| 1395 | (R)-3,4-DCPG |
| AMPA antagonist/weak NMDA antagonist | |
| 1396 | Fenretinide |
| Synthetic retinoid. Potent anti-cancer agent | |
| 1397 | PP 1 |
| Potent, selective Src inhibitor | |
| 1398 | Kenpaullone |
| Potent cyclin-dependent kinase inhibitor. Also inhibits GSK-3 | |
| 1399 | CP 339818 hydrochloride |
| Non-peptide, potent Kv1.3 channel blocker | |
| 1400 | SCH 202676 hydrobromide |
| Inhibitor of ligand binding to G-protein-coupled receptors | |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | All |
[top]